Background On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …

We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2
infection and with other ARDS. The differences in epidemiology and outcome will be detailed. …

Importance The benefit of high-dose dexamethasone and oxygenation strategies vs standard
of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused by …

Cefiderocol (FDC) is a siderophore cephalosporin now recognized as a new weapon in the
treatment of difficult-to-treat-resistant (DTR) Gram-negative pathogens, including …

Background Data in the literature about HSV reactivation in COVID-19 patients are scarce,
and the association between HSV-1 reactivation and mortality remains to be determined. Our …

We report a longitudinal analysis of the immune response associated with a fatal case of
COVID-19 in Europe. This patient exhibited a rapid evolution towards multiorgan failure. SARS-…

COVID-19 can cause acute respiratory distress syndrome, leading to death in many individuals.
Evidence of a deleterious role of the innate immune system is accumulating, but the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the
virus responsible for the coronavirus disease 2019 (COVID-19) outbreak worldwide. Data on …

Nosocomial pneumonia is associated with worsened prognosis when diagnosed in
intensive care unit (ICU), ranging from 12 to 48% mortality. The incidence rate of ventilation-acquired …

Remdesivir has reported efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in vitro and in vivo. Drug-drug interactions limit therapeutic options in …